Global Infectious Disease Testing Market Size, Status and Forecast 2021-2027

In hospitals, infectious disease specialists help ensure the timely diagnosis and treatment of acute infections by recommending the appropriate diagnostic tests to identify the source of the infection and by recommending the appropriate antibiotic to treat the infection.

Biochemical tests used in the identification of infectious agents include the detection of metabolic or enzymatic products characteristic of a particular infectious agent. Since bacteria ferment carbohydrates in patterns characteristic of their genus and species, the detection of fermentation products is commonly used in bacterial identification. Acids, alcohols and gases are usually detected in these tests when bacteria are grown in selective liquid or solid media.

Market Analysis and Insights: Global Infectious Disease Testing Market

The global Infectious Disease Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Infectious Disease Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Infectious Disease Testing market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Infectious Disease Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Infectious Disease Testing market.

Global Infectious Disease Testing Scope and Market Size

Infectious Disease Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Infectious Disease Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Technology and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Technology

Immunodiagnostics

Clinical Microbiology

PCR

INAAT

DNA Sequencing & NGS

DNA Microarrays

Other

Hospitals/Clinical Laboratories

Reference Laboratories

Academic/Research Institutes

Other

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Nordic

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Abbott Diagnostics

Abbott

Beckman Coulter Diagnostics

Roche

Siemens Healthcare

Abaxis

Acon Laboratories

Avioq

BD

Bio-Rad Laboratories

Cavidi

Cepheid

Chembio Diagnostic Systems

Clarity Diagnostics

EMD Millipore

Epitope Diagnostic

Gold Standard Diagnostics

Hologic

Immunetics

InBios International

Life Technologies

Maxim Biomedical

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Infectious Disease Testing Market Size Growth Rate by Technology: 2016 VS 2021 VS 2027

1.2.2 Immunodiagnostics

1.2.3 Clinical Microbiology

1.2.4 PCR

1.2.5 INAAT

1.2.6 DNA Sequencing & NGS

1.2.7 DNA Microarrays

1.2.8 Other

1.3 Market by Application

1.3.1 Global Infectious Disease Testing Market Share by Application: 2016 VS 2021 VS 2027

1.3.2 Hospitals/Clinical Laboratories

1.3.3 Reference Laboratories

1.3.4 Academic/Research Institutes

1.3.5 Other

1.4 Study Objectives

1.5 Years Considered

2.1 Global Infectious Disease Testing Market Perspective (2016-2027)

2.2 Infectious Disease Testing Growth Trends by Regions

2.2.1 Infectious Disease Testing Market Size by Regions: 2016 VS 2021 VS 2027

2.2.2 Infectious Disease Testing Historic Market Share by Regions (2016-2021)

2.2.3 Infectious Disease Testing Forecasted Market Size by Regions (2022-2027)

2.3 Infectious Disease Testing Industry Dynamic

2.3.1 Infectious Disease Testing Market Trends

2.3.2 Infectious Disease Testing Market Drivers

2.3.3 Infectious Disease Testing Market Challenges

2.3.4 Infectious Disease Testing Market Restraints

3.1 Global Top Infectious Disease Testing Players by Revenue

3.1.1 Global Top Infectious Disease Testing Players by Revenue (2016-2021)

3.1.2 Global Infectious Disease Testing Revenue Market Share by Players (2016-2021)

3.2 Global Infectious Disease Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.3 Players Covered: Ranking by Infectious Disease Testing Revenue

3.4 Global Infectious Disease Testing Market Concentration Ratio

3.4.1 Global Infectious Disease Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease Testing Revenue in 2020

3.5 Infectious Disease Testing Key Players Head office and Area Served

3.6 Key Players Infectious Disease Testing Product Solution and Service

3.7 Date of Enter into Infectious Disease Testing Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Infectious Disease Testing Historic Market Size by Technology (2016-2021)

4.2 Global Infectious Disease Testing Forecasted Market Size by Technology (2022-2027)

5.1 Global Infectious Disease Testing Historic Market Size by Application (2016-2021)

5.2 Global Infectious Disease Testing Forecasted Market Size by Application (2022-2027)

6.1 North America Infectious Disease Testing Market Size (2016-2027)

6.2 North America Infectious Disease Testing Market Size by Technology

6.2.1 North America Infectious Disease Testing Market Size by Technology (2016-2021)

6.2.2 North America Infectious Disease Testing Market Size by Technology (2022-2027)

6.2.3 North America Infectious Disease Testing Market Size by Technology (2016-2027)

6.3 North America Infectious Disease Testing Market Size by Application

6.3.1 North America Infectious Disease Testing Market Size by Application (2016-2021)

6.3.2 North America Infectious Disease Testing Market Size by Application (2022-2027)

6.3.3 North America Infectious Disease Testing Market Size by Application (2016-2027)

6.4 North America Infectious Disease Testing Market Size by Country

6.4.1 North America Infectious Disease Testing Market Size by Country (2016-2021)

6.4.2 North America Infectious Disease Testing Market Size by Country (2022-2027)

6.4.3 United States

6.4.4 Canada

7.1 Europe Infectious Disease Testing Market Size (2016-2027)

7.2 Europe Infectious Disease Testing Market Size by Technology

7.2.1 Europe Infectious Disease Testing Market Size by Technology (2016-2021)

7.2.2 Europe Infectious Disease Testing Market Size by Technology (2022-2027)

7.2.3 Europe Infectious Disease Testing Market Size by Technology (2016-2027)

7.3 Europe Infectious Disease Testing Market Size by Application

7.3.1 Europe Infectious Disease Testing Market Size by Application (2016-2021)

7.3.2 Europe Infectious Disease Testing Market Size by Application (2022-2027)

7.3.3 Europe Infectious Disease Testing Market Size by Application (2016-2027)

7.4 Europe Infectious Disease Testing Market Size by Country

7.4.1 Europe Infectious Disease Testing Market Size by Country (2016-2021)

7.4.2 Europe Infectious Disease Testing Market Size by Country (2022-2027)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic

8.1 Asia-Pacific Infectious Disease Testing Market Size (2016-2027)

8.2 Asia-Pacific Infectious Disease Testing Market Size by Technology

8.2.1 Asia-Pacific Infectious Disease Testing Market Size by Technology (2016-2021)

8.2.2 Asia-Pacific Infectious Disease Testing Market Size by Technology (2022-2027)

8.2.3 Asia-Pacific Infectious Disease Testing Market Size by Technology (2016-2027)

8.3 Asia-Pacific Infectious Disease Testing Market Size by Application

8.3.1 Asia-Pacific Infectious Disease Testing Market Size by Application (2016-2021)

8.3.2 Asia-Pacific Infectious Disease Testing Market Size by Application (2022-2027)

8.3.3 Asia-Pacific Infectious Disease Testing Market Size by Application (2016-2027)

8.4 Asia-Pacific Infectious Disease Testing Market Size by Region

8.4.1 Asia-Pacific Infectious Disease Testing Market Size by Region (2016-2021)

8.4.2 Asia-Pacific Infectious Disease Testing Market Size by Region (2022-2027)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9.1 Latin America Infectious Disease Testing Market Size (2016-2027)

9.2 Latin America Infectious Disease Testing Market Size by Technology

9.2.1 Latin America Infectious Disease Testing Market Size by Technology (2016-2021)

9.2.2 Latin America Infectious Disease Testing Market Size by Technology (2022-2027)

9.2.3 Latin America Infectious Disease Testing Market Size by Technology (2016-2027)

9.3 Latin America Infectious Disease Testing Market Size by Application

9.3.1 Latin America Infectious Disease Testing Market Size by Application (2016-2021)

9.3.2 Latin America Infectious Disease Testing Market Size by Application (2022-2027)

9.3.3 Latin America Infectious Disease Testing Market Size by Application (2016-2027)

9.4 Latin America Infectious Disease Testing Market Size by Country

9.4.1 Latin America Infectious Disease Testing Market Size by Country (2016-2021)

9.4.2 Latin America Infectious Disease Testing Market Size by Country (2022-2027)

9.4.3 Mexico

9.4.4 Brazil

10.1 Middle East & Africa Infectious Disease Testing Market Size (2016-2027)

10.2 Middle East & Africa Infectious Disease Testing Market Size by Technology

10.2.1 Middle East & Africa Infectious Disease Testing Market Size by Technology (2016-2021)

10.2.2 Middle East & Africa Infectious Disease Testing Market Size by Technology (2022-2027)

10.2.3 Middle East & Africa Infectious Disease Testing Market Size by Technology (2016-2027)

10.3 Middle East & Africa Infectious Disease Testing Market Size by Application

10.3.1 Middle East & Africa Infectious Disease Testing Market Size by Application (2016-2021)

10.3.2 Middle East & Africa Infectious Disease Testing Market Size by Application (2022-2027)

10.3.3 Middle East & Africa Infectious Disease Testing Market Size by Application (2016-2027)

10.4 Middle East & Africa Infectious Disease Testing Market Size by Country

10.4.1 Middle East & Africa Infectious Disease Testing Market Size by Country (2016-2021)

10.4.2 Middle East & Africa Infectious Disease Testing Market Size by Country (2022-2027)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11.1 Abbott Diagnostics

11.1.1 Abbott Diagnostics Company Details

11.1.2 Abbott Diagnostics Business Overview

11.1.3 Abbott Diagnostics Infectious Disease Testing Introduction

11.1.4 Abbott Diagnostics Revenue in Infectious Disease Testing Business (2016-2021)

11.1.5 Abbott Diagnostics Recent Development

11.2 Abbott

11.2.1 Abbott Company Details

11.2.2 Abbott Business Overview

11.2.3 Abbott Infectious Disease Testing Introduction

11.2.4 Abbott Revenue in Infectious Disease Testing Business (2016-2021)

11.2.5 Abbott Recent Development

11.3 Beckman Coulter Diagnostics

11.3.1 Beckman Coulter Diagnostics Company Details

11.3.2 Beckman Coulter Diagnostics Business Overview

11.3.3 Beckman Coulter Diagnostics Infectious Disease Testing Introduction

11.3.4 Beckman Coulter Diagnostics Revenue in Infectious Disease Testing Business (2016-2021)

11.3.5 Beckman Coulter Diagnostics Recent Development

11.4 Roche

11.4.1 Roche Company Details

11.4.2 Roche Business Overview

11.4.3 Roche Infectious Disease Testing Introduction

11.4.4 Roche Revenue in Infectious Disease Testing Business (2016-2021)

11.4.5 Roche Recent Development

11.5 Siemens Healthcare

11.5.1 Siemens Healthcare Company Details

11.5.2 Siemens Healthcare Business Overview

11.5.3 Siemens Healthcare Infectious Disease Testing Introduction

11.5.4 Siemens Healthcare Revenue in Infectious Disease Testing Business (2016-2021)

11.5.5 Siemens Healthcare Recent Development

11.6 Abaxis

11.6.1 Abaxis Company Details

11.6.2 Abaxis Business Overview

11.6.3 Abaxis Infectious Disease Testing Introduction

11.6.4 Abaxis Revenue in Infectious Disease Testing Business (2016-2021)

11.6.5 Abaxis Recent Development

11.7 Acon Laboratories

11.7.1 Acon Laboratories Company Details

11.7.2 Acon Laboratories Business Overview

11.7.3 Acon Laboratories Infectious Disease Testing Introduction

11.7.4 Acon Laboratories Revenue in Infectious Disease Testing Business (2016-2021)

11.7.5 Acon Laboratories Recent Development

11.8 Avioq

11.8.1 Avioq Company Details

11.8.2 Avioq Business Overview

11.8.3 Avioq Infectious Disease Testing Introduction

11.8.4 Avioq Revenue in Infectious Disease Testing Business (2016-2021)

11.8.5 Avioq Recent Development

11.9 BD

11.9.1 BD Company Details

11.9.2 BD Business Overview

11.9.3 BD Infectious Disease Testing Introduction

11.9.4 BD Revenue in Infectious Disease Testing Business (2016-2021)

11.9.5 BD Recent Development

11.10 Bio-Rad Laboratories

11.10.1 Bio-Rad Laboratories Company Details

11.10.2 Bio-Rad Laboratories Business Overview

11.10.3 Bio-Rad Laboratories Infectious Disease Testing Introduction

11.10.4 Bio-Rad Laboratories Revenue in Infectious Disease Testing Business (2016-2021)

11.10.5 Bio-Rad Laboratories Recent Development

11.11 Cavidi

11.11.1 Cavidi Company Details

11.11.2 Cavidi Business Overview

11.11.3 Cavidi Infectious Disease Testing Introduction

11.11.4 Cavidi Revenue in Infectious Disease Testing Business (2016-2021)

11.11.5 Cavidi Recent Development

11.12 Cepheid

11.12.1 Cepheid Company Details

11.12.2 Cepheid Business Overview

11.12.3 Cepheid Infectious Disease Testing Introduction

11.12.4 Cepheid Revenue in Infectious Disease Testing Business (2016-2021)

11.12.5 Cepheid Recent Development

11.13 Chembio Diagnostic Systems

11.13.1 Chembio Diagnostic Systems Company Details

11.13.2 Chembio Diagnostic Systems Business Overview

11.13.3 Chembio Diagnostic Systems Infectious Disease Testing Introduction

11.13.4 Chembio Diagnostic Systems Revenue in Infectious Disease Testing Business (2016-2021)

11.13.5 Chembio Diagnostic Systems Recent Development

11.14 Clarity Diagnostics

11.14.1 Clarity Diagnostics Company Details

11.14.2 Clarity Diagnostics Business Overview

11.14.3 Clarity Diagnostics Infectious Disease Testing Introduction

11.14.4 Clarity Diagnostics Revenue in Infectious Disease Testing Business (2016-2021)

11.14.5 Clarity Diagnostics Recent Development

11.15 EMD Millipore

11.15.1 EMD Millipore Company Details

11.15.2 EMD Millipore Business Overview

11.15.3 EMD Millipore Infectious Disease Testing Introduction

11.15.4 EMD Millipore Revenue in Infectious Disease Testing Business (2016-2021)

11.15.5 EMD Millipore Recent Development

11.16 Epitope Diagnostic

11.16.1 Epitope Diagnostic Company Details

11.16.2 Epitope Diagnostic Business Overview

11.16.3 Epitope Diagnostic Infectious Disease Testing Introduction

11.16.4 Epitope Diagnostic Revenue in Infectious Disease Testing Business (2016-2021)

11.16.5 Epitope Diagnostic Recent Development

11.17 Gold Standard Diagnostics

11.17.1 Gold Standard Diagnostics Company Details

11.17.2 Gold Standard Diagnostics Business Overview

11.17.3 Gold Standard Diagnostics Infectious Disease Testing Introduction

11.17.4 Gold Standard Diagnostics Revenue in Infectious Disease Testing Business (2016-2021)

11.17.5 Gold Standard Diagnostics Recent Development

11.18 Hologic

11.18.1 Hologic Company Details

11.18.2 Hologic Business Overview

11.18.3 Hologic Infectious Disease Testing Introduction

11.18.4 Hologic Revenue in Infectious Disease Testing Business (2016-2021)

11.18.5 Hologic Recent Development

11.18 Immunetics

.1 Immunetics Company Details

.2 Immunetics Business Overview

.3 Immunetics Infectious Disease Testing Introduction

.4 Immunetics Revenue in Infectious Disease Testing Business (2016-2021)

.5 Immunetics Recent Development

11.20 InBios International

11.20.1 InBios International Company Details

11.20.2 InBios International Business Overview

11.20.3 InBios International Infectious Disease Testing Introduction

11.20.4 InBios International Revenue in Infectious Disease Testing Business (2016-2021)

11.20.5 InBios International Recent Development

11.21 Life Technologies

11.21.1 Life Technologies Company Details

11.21.2 Life Technologies Business Overview

11.21.3 Life Technologies Infectious Disease Testing Introduction

11.21.4 Life Technologies Revenue in Infectious Disease Testing Business (2016-2021)

11.21.5 Life Technologies Recent Development

11.22 Maxim Biomedical

11.22.1 Maxim Biomedical Company Details

11.22.2 Maxim Biomedical Business Overview

11.22.3 Maxim Biomedical Infectious Disease Testing Introduction

11.22.4 Maxim Biomedical Revenue in Infectious Disease Testing Business (2016-2021)

11.22.5 Maxim Biomedical Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Infectious Disease Testing Market Size Growth Rate by Technology (US$ Million):2016 VS 2021 VS 2027

    Table 2. Key Players of Immunodiagnostics

    Table 3. Key Players of Clinical Microbiology

    Table 4. Key Players of PCR

    Table 5. Key Players of INAAT

    Table 6. Key Players of DNA Sequencing & NGS

    Table 7. Key Players of DNA Microarrays

    Table 8. Key Players of Other

    Table 9. Global Infectious Disease Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027

    Table 10. Global Infectious Disease Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027

    Table 11. Global Infectious Disease Testing Market Size by Regions (2016-2021) & (US$ Million)

    Table 12. Global Infectious Disease Testing Market Share by Regions (2016-2021)

    Table 13. Global Infectious Disease Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)

    Table 14. Global Infectious Disease Testing Market Share by Regions (2022-2027)

    Table 15. Infectious Disease Testing Market Trends

    Table 16. Infectious Disease Testing Market Drivers

    Table 17. Infectious Disease Testing Market Challenges

    Table 18. Infectious Disease Testing Market Restraints

    Table 19. Global Infectious Disease Testing Revenue by Players (2016-2021) & (US$ Million)

    Table 20. Global Infectious Disease Testing Market Share by Players (2016-2021)

    Table 21. Global Top Infectious Disease Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Disease Testing as of 2020)

    Table 22. Ranking of Global Top Infectious Disease Testing Companies by Revenue (US$ Million) in 2020

    Table 23. Global 5 Largest Players Market Share by Infectious Disease Testing Revenue (CR5 and HHI) & (2016-2021)

    Table 24. Key Players Headquarters and Area Served

    Table 25. Key Players Infectious Disease Testing Product Solution and Service

    Table 26. Date of Enter into Infectious Disease Testing Market

    Table 27. Mergers & Acquisitions, Expansion Plans

    Table 28. Global Infectious Disease Testing Market Size by Technology (2016-2021) (US$ Million)

    Table 29. Global Infectious Disease Testing Revenue Market Share by Technology (2016-2021)

    Table 30. Global Infectious Disease Testing Forecasted Market Size by Technology (2022-2027) (US$ Million)

    Table 31. Global Infectious Disease Testing Revenue Market Share by Technology (2022-2027) & (US$ Million)

    Table 32. Global Infectious Disease Testing Market Size Share by Application (2016-2021) & (US$ Million)

    Table 33. Global Infectious Disease Testing Revenue Market Share by Application (2016-2021)

    Table 34. Global Infectious Disease Testing Forecasted Market Size by Application (2022-2027) (US$ Million)

    Table 35. Global Infectious Disease Testing Revenue Market Share by Application (2022-2027) & (US$ Million)

    Table 36. North America Infectious Disease Testing Market Size by Technology (2016-2021) (US$ Million)

    Table 37. North America Infectious Disease Testing Market Size by Technology (2022-2027) & (US$ Million)

    Table 38. North America Infectious Disease Testing Market Size by Application (2016-2021) (US$ Million)

    Table 39. North America Infectious Disease Testing Market Size by Application (2022-2027) & (US$ Million)

    Table 40. North America Infectious Disease Testing Market Size by Country (2016-2021) & (US$ Million)

    Table 41. North America Infectious Disease Testing Market Size by Country (2022-2027) & (US$ Million)

    Table 42. Europe Infectious Disease Testing Market Size by Technology (2016-2021) (US$ Million)

    Table 43. Europe Infectious Disease Testing Market Size by Technology (2022-2027) & (US$ Million)

    Table 44. Europe Infectious Disease Testing Market Size by Application (2016-2021) (US$ Million)

    Table 45. Europe Infectious Disease Testing Market Size by Application (2022-2027) & (US$ Million)

    Table 46. Europe Infectious Disease Testing Market Size by Country (2016-2021) & (US$ Million)

    Table 47. Europe Infectious Disease Testing Market Size by Country (2022-2027) & (US$ Million)

    Table 48. Asia-Pacific Infectious Disease Testing Market Size by Technology (2016-2021) (US$ Million)

    Table 49. Asia-Pacific Infectious Disease Testing Market Size by Technology (2022-2027) & (US$ Million)

    Table 50. Asia-Pacific Infectious Disease Testing Market Size by Application (2016-2021) (US$ Million)

    Table 51. Asia-Pacific Infectious Disease Testing Market Size by Application (2022-2027) & (US$ Million)

    Table 52. Asia-Pacific Infectious Disease Testing Market Size by Region (2016-2021) & (US$ Million)

    Table 53. Asia-Pacific Infectious Disease Testing Market Size by Region (2022-2027) & (US$ Million)

    Table 54. Latin America Infectious Disease Testing Market Size by Technology (2016-2021) (US$ Million)

    Table 55. Latin America Infectious Disease Testing Market Size by Technology (2022-2027) & (US$ Million)

    Table 56. Latin America Infectious Disease Testing Market Size by Application (2016-2021) (US$ Million)

    Table 57. Latin America Infectious Disease Testing Market Size by Application (2022-2027) & (US$ Million)

    Table 58. Latin America Infectious Disease Testing Market Size by Country (2016-2021) & (US$ Million)

    Table 59. Latin America Infectious Disease Testing Market Size by Country (2022-2027) & (US$ Million)

    Table 60. Middle East & Africa Infectious Disease Testing Market Size by Technology (2016-2021) (US$ Million)

    Table 61. Middle East & Africa Infectious Disease Testing Market Size by Technology (2022-2027) & (US$ Million)

    Table 62. Middle East & Africa Infectious Disease Testing Market Size by Application (2016-2021) (US$ Million)

    Table 63. Middle East & Africa Infectious Disease Testing Market Size by Application (2022-2027) & (US$ Million)

    Table 64. Middle East & Africa Infectious Disease Testing Market Size by Country (2016-2021) & (US$ Million)

    Table 65. Middle East & Africa Infectious Disease Testing Market Size by Country (2022-2027) & (US$ Million)

    Table 66. Abbott Diagnostics Company Details

    Table 67. Abbott Diagnostics Business Overview

    Table 68. Abbott Diagnostics Infectious Disease Testing Product

    Table 69. Abbott Diagnostics Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million)

    Table 70. Abbott Diagnostics Recent Development

    Table 71. Abbott Company Details

    Table 72. Abbott Business Overview

    Table 73. Abbott Infectious Disease Testing Product

    Table 74. Abbott Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million)

    Table 75. Abbott Recent Development

    Table 76. Beckman Coulter Diagnostics Company Details

    Table 77. Beckman Coulter Diagnostics Business Overview

    Table 78. Beckman Coulter Diagnostics Infectious Disease Testing Product

    Table 79. Beckman Coulter Diagnostics Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million)

    Table 80. Beckman Coulter Diagnostics Recent Development

    Table 81. Roche Company Details

    Table 82. Roche Business Overview

    Table 83. Roche Infectious Disease Testing Product

    Table 84. Roche Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million)

    Table 85. Roche Recent Development

    Table 86. Siemens Healthcare Company Details

    Table 87. Siemens Healthcare Business Overview

    Table 88. Siemens Healthcare Infectious Disease Testing Product

    Table 89. Siemens Healthcare Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million)

    Table 90. Siemens Healthcare Recent Development

    Table 91. Abaxis Company Details

    Table 92. Abaxis Business Overview

    Table 93. Abaxis Infectious Disease Testing Product

    Table 94. Abaxis Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million)

    Table 95. Abaxis Recent Development

    Table 96. Acon Laboratories Company Details

    Table 97. Acon Laboratories Business Overview

    Table 98. Acon Laboratories Infectious Disease Testing Product

    Table 99. Acon Laboratories Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million)

    Table 100. Acon Laboratories Recent Development

    Table 101. Avioq Company Details

    Table 102. Avioq Business Overview

    Table 103. Avioq Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million)

    Table 104. Avioq Recent Development

    Table 105. BD Company Details

    Table 106. BD Business Overview

    Table 107. BD Infectious Disease Testing Product

    Table 108. BD Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million)

    Table 109. BD Recent Development

    Table 110. Bio-Rad Laboratories Company Details

    Table 111. Bio-Rad Laboratories Business Overview

    Table 112. Bio-Rad Laboratories Infectious Disease Testing Product

    Table 113. Bio-Rad Laboratories Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million)

    Table 114. Bio-Rad Laboratories Recent Development

    Table 115. Cavidi Company Details

    Table 116. Cavidi Business Overview

    Table 117. Cavidi Infectious Disease Testing Product

    Table 118. Cavidi Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million)

    Table 119. Cavidi Recent Development

    Table 120. Cepheid Company Details

    Table 121. Cepheid Business Overview

    Table 122. Cepheid Infectious Disease Testing Product

    Table 123. Cepheid Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million)

    Table 124. Cepheid Recent Development

    Table 125. Chembio Diagnostic Systems Company Details

    Table 126. Chembio Diagnostic Systems Business Overview

    Table 127. Chembio Diagnostic Systems Infectious Disease Testing Product

    Table 128. Chembio Diagnostic Systems Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million)

    Table 129. Chembio Diagnostic Systems Recent Development

    Table 130. Clarity Diagnostics Company Details

    Table 131. Clarity Diagnostics Business Overview

    Table 132. Clarity Diagnostics Infectious Disease Testing Product

    Table 133. Clarity Diagnostics Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million)

    Table 134. Clarity Diagnostics Recent Development

    Table 135. EMD Millipore Company Details

    Table 136. EMD Millipore Business Overview

    Table 137. EMD Millipore Infectious Disease Testing Product

    Table 138. EMD Millipore Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million)

    Table 139. EMD Millipore Recent Development

    Table 140. Epitope Diagnostic Company Details

    Table 141. Epitope Diagnostic Business Overview

    Table 142. Epitope Diagnostic Infectious Disease Testing Product

    Table 143. Epitope Diagnostic Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million)

    Table 144. Epitope Diagnostic Recent Development

    Table 145. Gold Standard Diagnostics Company Details

    Table 146. Gold Standard Diagnostics Business Overview

    Table 147. Gold Standard Diagnostics Infectious Disease Testing Product

    Table 148. Gold Standard Diagnostics Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million)

    Table 149. Gold Standard Diagnostics Recent Development

    Table 150. Hologic Company Details

    Table 151. Hologic Business Overview

    Table 152. Hologic Infectious Disease Testing Product

    Table 153. Hologic Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million)

    Table 154. Hologic Recent Development

    Table 155. Immunetics Company Details

    Table 156. Immunetics Business Overview

    Table 157. Immunetics Infectious Disease Testing Product

    Table 158. Immunetics Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million)

    Table 159. Immunetics Recent Development

    Table 160. InBios International Company Details

    Table 161. InBios International Business Overview

    Table 162. InBios International Infectious Disease Testing Product

    Table 163. InBios International Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million)

    Table 164. InBios International Recent Development

    Table 165. Life Technologies Company Details

    Table 166. Life Technologies Business Overview

    Table 167. Life Technologies Infectious Disease Testing Product

    Table 168. Life Technologies Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million)

    Table 169. Life Technologies Recent Development

    Table 170. Maxim Biomedical Company Details

    Table 171. Maxim Biomedical Business Overview

    Table 172. Maxim Biomedical Infectious Disease Testing Product

    Table 173. Maxim Biomedical Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million)

    Table 174. Maxim Biomedical Recent Development

    Table 175. Research Programs/Design for This Report

    Table 176. Key Data Information from Secondary Sources

    Table 177. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Infectious Disease Testing Market Share by Technology: 2020 VS 2027

    Figure 2. Immunodiagnostics Features

    Figure 3. Clinical Microbiology Features

    Figure 4. PCR Features

    Figure 5. INAAT Features

    Figure 6. DNA Sequencing & NGS Features

    Figure 7. DNA Microarrays Features

    Figure 8. Other Features

    Figure 9. Global Infectious Disease Testing Market Share by Application: 2020 VS 2027

    Figure 10. Hospitals/Clinical Laboratories Case Studies

    Figure 11. Reference Laboratories Case Studies

    Figure 12. Academic/Research Institutes Case Studies

    Figure 13. Other Case Studies

    Figure 14. Infectious Disease Testing Report Years Considered

    Figure 15. Global Infectious Disease Testing Market Size (US$ Million), Year-over-Year: 2016-2027

    Figure 16. Global Infectious Disease Testing Market Size (US$ Million), 2016 VS 2021 VS 2027

    Figure 17. Global Infectious Disease Testing Market Share by Regions: 2020 VS 2027

    Figure 18. Global Infectious Disease Testing Market Share by Regions (2022-2027)

    Figure 19. Global Infectious Disease Testing Market Share by Players in 2020

    Figure 20. Global Top Infectious Disease Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Disease Testing as of 2020

    Figure 21. The Top 10 and 5 Players Market Share by Infectious Disease Testing Revenue in 2020

    Figure 22. Global Infectious Disease Testing Revenue Market Share by Technology (2016-2021)

    Figure 23. Global Infectious Disease Testing Revenue Market Share by Technology (2022-2027)

    Figure 24. North America Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 25. North America Infectious Disease Testing Market Share by Technology (2016-2027)

    Figure 26. North America Infectious Disease Testing Market Share by Application (2016-2027)

    Figure 27. North America Infectious Disease Testing Market Share by Country (2016-2027)

    Figure 28. United States Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 29. Canada Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 30. Europe Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 31. Europe Infectious Disease Testing Market Share by Technology (2016-2027)

    Figure 32. Europe Infectious Disease Testing Market Share by Application (2016-2027)

    Figure 33. Europe Infectious Disease Testing Market Share by Country (2016-2027)

    Figure 34. Germany Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 35. France Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 36. U.K. Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 37. Italy Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 38. Russia Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 39. Nordic Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 40. Asia-Pacific Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 41. Asia-Pacific Infectious Disease Testing Market Share by Technology (2016-2027)

    Figure 42. Asia-Pacific Infectious Disease Testing Market Share by Application (2016-2027)

    Figure 43. Asia-Pacific Infectious Disease Testing Market Share by Region (2016-2027)

    Figure 44. China Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 45. Japan Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 46. South Korea Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 47. Southeast Asia Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 48. India Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 49. Australia Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 50. Latin America Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 51. Latin America Infectious Disease Testing Market Share by Technology (2016-2027)

    Figure 52. Latin America Infectious Disease Testing Market Share by Application (2016-2027)

    Figure 53. Latin America Infectious Disease Testing Market Share by Country (2016-2027)

    Figure 54. Mexico Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 55. Brazil Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 56. Middle East & Africa Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 57. Middle East & Africa Infectious Disease Testing Market Share by Technology (2016-2027)

    Figure 58. Middle East & Africa Infectious Disease Testing Market Share by Application (2016-2027)

    Figure 59. Middle East & Africa Infectious Disease Testing Market Share by Country (2016-2027)

    Figure 60. Turkey Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 61. Saudi Arabia Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 62. UAE Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 63. Abbott Diagnostics Revenue Growth Rate in Infectious Disease Testing Business (2016-2021)

    Figure 64. Abbott Revenue Growth Rate in Infectious Disease Testing Business (2016-2021)

    Figure 65. Beckman Coulter Diagnostics Revenue Growth Rate in Infectious Disease Testing Business (2016-2021)

    Figure 66. Roche Revenue Growth Rate in Infectious Disease Testing Business (2016-2021)

    Figure 67. Siemens Healthcare Revenue Growth Rate in Infectious Disease Testing Business (2016-2021)

    Figure 68. Abaxis Revenue Growth Rate in Infectious Disease Testing Business (2016-2021)

    Figure 69. Acon Laboratories Revenue Growth Rate in Infectious Disease Testing Business (2016-2021)

    Figure 70. Avioq Revenue Growth Rate in Infectious Disease Testing Business (2016-2021)

    Figure 71. BD Revenue Growth Rate in Infectious Disease Testing Business (2016-2021)

    Figure 72. Bio-Rad Laboratories Revenue Growth Rate in Infectious Disease Testing Business (2016-2021)

    Figure 73. Cavidi Revenue Growth Rate in Infectious Disease Testing Business (2016-2021)

    Figure 74. Cepheid Revenue Growth Rate in Infectious Disease Testing Business (2016-2021)

    Figure 75. Chembio Diagnostic Systems Revenue Growth Rate in Infectious Disease Testing Business (2016-2021)

    Figure 76. Clarity Diagnostics Revenue Growth Rate in Infectious Disease Testing Business (2016-2021)

    Figure 77. EMD Millipore Revenue Growth Rate in Infectious Disease Testing Business (2016-2021)

    Figure 78. Epitope Diagnostic Revenue Growth Rate in Infectious Disease Testing Business (2016-2021)

    Figure 79. Gold Standard Diagnostics Revenue Growth Rate in Infectious Disease Testing Business (2016-2021)

    Figure 80. Hologic Revenue Growth Rate in Infectious Disease Testing Business (2016-2021)

    Figure 81. Immunetics Revenue Growth Rate in Infectious Disease Testing Business (2016-2021)

    Figure 82. InBios International Revenue Growth Rate in Infectious Disease Testing Business (2016-2021)

    Figure 83. Life Technologies Revenue Growth Rate in Infectious Disease Testing Business (2016-2021)

    Figure 84. Maxim Biomedical Revenue Growth Rate in Infectious Disease Testing Business (2016-2021)

    Figure 85. Bottom-up and Top-down Approaches for This Report

    Figure 86. Data Triangulation

    Figure 87. Key Executives Interviewed